H. saimiri tyrosine-kinase interacting protein inhibits Tat function: a prototypic strategy for restricting HIV-1-induced cytopathic effects in immune cells

Virology. 2006 Sep 1;352(2):253-67. doi: 10.1016/j.virol.2006.04.016. Epub 2006 Jun 15.

Abstract

Herpesvirus saimiri (HVS)-transformed human T cells become permissive for X4 and R5 strains of human immunodeficiency virus type 1 (HIV-1), evidence that HVS-encoded proteins associated with T cell transformation enhance HIV-1 replication. Analyzing the contribution of transformation-associated bicistronic HVS open reading frames (ORF) to HIV-1 replication revealed expression of the second ORF saimiri transformation-associated protein type C (StpC) conferred the permissive phenotype to T cells. In contrast, expression of the first HVS ORF tyrosine-kinase interacting protein (Tip) in the absence of StpC enhanced restriction of HIV-1 replication in T cell lines and peripheral blood mononuclear cells. Understanding the mechanism whereby Tip enhanced restriction of HIV-1 replication may uncover unique pathways that could be targeted therapeutically. Here we report that Tip restricts HIV-1 replication in a monocyte-derived cell line and restricts reactivation of replication of HIV-1 in a T cell line harboring provirus. In this report, we begin to unravel the molecular underpinnings of Tip-mediated restriction. Tip mediates both lymphocyte-cell-specific kinase (Lck)-dependent and -independent effects on HIV-1 replication. We also provide evidence that Tip-mediated restriction is in part due to inhibition of Tat transactivation of the HIV-1 long terminal repeat (LTR). Expression of Tip in T cells increased activation of Stat1 and Stat3, as well as activation of protein kinase RNA-dependent (PKR/p68) and interferon-gamma production. Taken together, these results provide evidence that Tip restricts HIV-1 replication and reactivation by inhibiting HIV-1 transcription while inducing an intercellular antiviral state. We propose that genetically engineered vectors driving Tip expression could provide a prototypic strategy for restricting HIV-1 replication and reactivation in diverse cell lineages.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line
  • Cytopathogenic Effect, Viral
  • Gene Products, tat / antagonists & inhibitors*
  • HIV Long Terminal Repeat
  • HIV-1 / immunology
  • HIV-1 / pathogenicity*
  • HIV-1 / physiology
  • Herpesvirus 2, Saimiriine / genetics
  • Herpesvirus 2, Saimiriine / metabolism*
  • Humans
  • Jurkat Cells
  • Lymphocyte Specific Protein Tyrosine Kinase p56(lck) / metabolism
  • Monocytes / immunology
  • Monocytes / metabolism
  • Monocytes / virology
  • Phosphoproteins / genetics
  • Phosphoproteins / metabolism*
  • STAT1 Transcription Factor / metabolism
  • STAT3 Transcription Factor / metabolism
  • T-Lymphocytes / immunology
  • T-Lymphocytes / metabolism
  • T-Lymphocytes / virology
  • Transduction, Genetic
  • Transformation, Genetic
  • U937 Cells
  • Viral Proteins / genetics
  • Viral Proteins / metabolism*
  • Virus Replication
  • eIF-2 Kinase / metabolism
  • tat Gene Products, Human Immunodeficiency Virus

Substances

  • Gene Products, tat
  • Phosphoproteins
  • STAT1 Transcription Factor
  • STAT1 protein, human
  • STAT3 Transcription Factor
  • STAT3 protein, human
  • Viral Proteins
  • tat Gene Products, Human Immunodeficiency Virus
  • tyrosine kinase interacting protein, Saimiriine herpesvirus 2
  • Lymphocyte Specific Protein Tyrosine Kinase p56(lck)
  • eIF-2 Kinase